The forecasted number of confirmed Rifampicin Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) cases in Italy shows a gradual decline. From 2023, where there were approximately 54 cases, predictions for the coming years indicate a steady reduction, reaching 46 cases by 2028. The year-on-year percentage variation from 2024 to 2028 shows a decrease ranging from 1.92% to 4%. The compound annual growth rate (CAGR) over this five-year period is slightly negative, at about -3.1%, reflecting an overall positive trend toward fewer cases.

Future trends to watch for include:

The impact of ongoing public health interventions on RR-/MDR-TB case reduction.
The effectiveness of new treatment regimens and tuberculosis management programs.
Potential emergence of new drug-resistant strains that could impact forecast trends.
Global efforts in tackling tuberculosis that might influence local outcomes in Italy.